|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1993-2-11
|
|
pubmed:abstractText |
After the discovery of type C hepatitis virus, the studies on this virus are extensively progressing. The treatment of this viral infection is also widely progressing. Among many agents, recombinant interferon alpha therapy is generally accepted as an effective single agent. To evaluate the efficacy of interferon and to observe the changes of serum aminotransferase (ALT), antibody to hepatitis C virus (anti-HCV) and HCV ribonucleic acid (HCV-RNA), we treated 10 patients with chronic type C hepatitis for 6 months.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1226-3303
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
13-7
|
|
pubmed:dateRevised |
2006-9-26
|
|
pubmed:meshHeading |
pubmed-meshheading:1282364-Adult,
pubmed-meshheading:1282364-Alanine Transaminase,
pubmed-meshheading:1282364-Base Sequence,
pubmed-meshheading:1282364-DNA, Viral,
pubmed-meshheading:1282364-Female,
pubmed-meshheading:1282364-Hepacivirus,
pubmed-meshheading:1282364-Hepatitis Antibodies,
pubmed-meshheading:1282364-Hepatitis C,
pubmed-meshheading:1282364-Hepatitis C Antibodies,
pubmed-meshheading:1282364-Humans,
pubmed-meshheading:1282364-Interferon-alpha,
pubmed-meshheading:1282364-Male,
pubmed-meshheading:1282364-Middle Aged,
pubmed-meshheading:1282364-Molecular Sequence Data
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Interferon alpha therapy in patients with chronic type C hepatitis: changes of serum ALT, anti-HCV & HCV-RNA.
|
|
pubmed:affiliation |
Department of Internal Medicine, College of Medicine, Hallym University, Seoul, Korea.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
